COMMUNIQUÉS West-GlobeNewswire

Metabo Drops Investigated: Is It Worth It in 2026? Truth Behind the Liquid Metabolism Drops
15/01/2026
New York City, NY, Jan. 15, 2026 (GLOBE NEWSWIRE) -- As metabolism supplements continue to grow in popularity in 2026, many consumers are seeking clear, factual information to better understand how these products differ [...]
Berberine Moringa NAD+ Patches Gaining Consumer Interest: Guide to Transdermal Supplement Delivery vs. Capsules
15/01/2026
Independent Research Examines Nano Microneedle Technology, Bioavailability Science, and Consumer Evaluation Criteria for Transdermal NAD+ and Berberine Formats SAN LEANDRO, CA, Jan. 15, 2026 (GLOBE NEWSWIRE) -- [...]
Greenhouse Treatment Center Welcomes New Harvard-Trained Addiction Treatment Expert
15/01/2026
GRAND PRAIRIE, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Greenhouse Treatment Center, a leading addiction rehab center in Dallas has added a new Harvard-trained physician, Dr. Queeneth Uwandu, MD, to its medical team. Dr [...]
Oncolytics Biotech® Announces Results of Special Meeting of Shareholders
15/01/2026
All resolutions passed, enabling the Company to streamline regulatory and operational processes SAN DIEGO, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“ Oncolytics ” or the “ Company ”), [...]
Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
15/01/2026
IRVINE, Calif., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its fourth [...]
BriaCell Therapeutics Announces Closing of US$30 million Public Offering
15/01/2026
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that [...]
Foundation for Sarcoidosis Research Announces New Members to the Expanding FSR Global Sarcoidosis Clinic Alliance, Including Its First International Member
15/01/2026
CHICAGO, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) proudly announces the addition of seven new institutions to its growing FSR Global Sarcoidosis Clinic Alliance (FSR-GSCA) : [...]
Is that assistance dog “real” and properly qualified? Assistance Dog Foundation Launches Independent ISO-Aligned Certification and Global Register for Assistance Dog Teams
15/01/2026
New Independent Non-Profit Uses Cutting-Edge Certification Technology to Provide ISO-aligned ID to Assistance Dog Teams The Hague, Netherlands, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The Assistance Dog Foundation , a newly [...]
Johns Hopkins USFHP Introduces No-Cost Mental Health Support Program for Members
15/01/2026
Cabana Live Offers Confidential Peer Support Services with No Out-of-Pocket Costs HANOVER, Md., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Johns Hopkins US Family Health Plan (USFHP) has added a new mental health and peer [...]
Compass Health Announces Opening of Crisis Triage Center at Marc Healing Center, Offering 24/7 Behavioral Health Crisis Care to Community Members Regionwide
15/01/2026
16-bed crisis triage center is the final program to launch in new state-of-the-art facility, following the December 2025 opening of the 16-bed Evaluation and Treatment Unit (E&T) EVERETT, Wash., Jan. 15, 2026 (GLOBE [...]
Prestige Senior Living Celebrates 40-Year Legacy, Expands Portfolio, and Launches Proprietary Decision Intelligence Tools
15/01/2026
Fourth-generation leadership grows managed communities from 13 to 24 and licenses SNFiQ/SLiQ to 70 senior care locations in the first year VANCOUVER, Wash., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Prestige Senior Living , an [...]
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital
15/01/2026
No Shareholder Action Required at This Time BETHLEHEM, Pa., Jan. 15, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure” and “OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and [...]
Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®
15/01/2026
Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked No. 6 nationally for Urology by US News & World Report ® for 2025-26 [...]
Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
15/01/2026
Among monotherapy expansion cohorts (n=21), ORR was 50% in patients treated with MDNA11 in 2L/3L setting and 42% when MDNA11 was the next treatment post-ICI failure, showing best-in-class potential for advanced cancer [...]
Cardiac Biotech Solutions Activates China Production Pipeline for MyCardia AT and Moves into Final NMPA Submission Phase
15/01/2026
Regulated manufacturing, hospital field trials, and regulatory filings now underway with Ebulent Medical in Shenzhen LAS VEGAS, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Cardiac Biotech Solutions, Inc. ( OTCID: CBSC ) (“CBSC” [...]
R1 Prior Authorization, Now Powered by the Phare OS, Accelerates Care, Reduces Costs and Improves Accuracy
15/01/2026
Combines AI-Powered Technology with R1 Experts to Set a New Standard for Clearance and Denial Rates CHICAGO, Jan. 15, 2026 (GLOBE NEWSWIRE) -- R1 (“R1” or the “Company”), the leader in healthcare revenue management, [...]
Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants
15/01/2026
Vaccine was safe and well-tolerated and led to a significant increase in norovirus-specific antibodies in serum and breast milk Norovirus-specific IgA in infant stool correlated with breast milk IgA, suggesting passive [...]
Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference
15/01/2026
STOUGHTON, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have four poster presentations highlighting real-world data from its ADHD product, Jornay PM ( [...]
ViroMissile Appoints Michael G. Wood as Chief Business Officer
15/01/2026
SAN DIEGO, Jan. 15, 2026 (GLOBE NEWSWIRE) -- ViroMissile , Inc., a cancer immunotherapy company pioneering the IDOV™ (Intravenously Deliverable Oncolytic Virus) platform, today announced the appointment of Michael G. [...]

Pages